Reimagining Gene Therapy
Kriya is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. We aim to revolutionize how gene therapies are designed, developed and manufactured – improving speed to market and delivering significant reductions in the cost per dose. Using our computationally enabled platform for rational vector design, SIRVE™, and our high-efficiency manufacturing platform, STRIPE™, we are advancing a deep and diversified pipeline of innovative gene therapies spanning rare and prevalent diseases in multiple therapeutic areas.
We believe that rationally engineered and manufactured gene therapies can transform the treatment of a broad universe of diseases – and we are prepared to lead this revolution in medicine.
Our Technology
SIRVE™ is our proprietary computationally-enabled platform for rational vector design, sequence modification, and data analysis. We are deploying SIRVE to advance a pipeline of gene therapies addressing a range of diseases.
Our Team
We have deep expertise in the field of gene therapy, with a team of pioneering veterans who have decades of experience at leading gene therapy companies and academic institutions
Manufacturing
Our proprietary high-efficiency manufacturing platform, STRIPE™, integrates the latest advances in cell line technology and process sciences. We are developing STRIPE at our 51,000 square foot manufacturing facility located in Research Triangle Park, North Carolina, one of the global centers for manufacturing in the biologics industry – with a goal of supporting the modular production of gene therapies at larger scale and substantially lower cost than current industry norms in gene therapy.
Top Talent in Top Locations
BAY AREA
California
RESEARCH TRIANGLE PARK
North Carolina
Investors
